Liberty1: An International Phase 3 Randomized, Double-blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co- Administered with and Without Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids